Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00000838
Ignite Creation Date: 2024-05-05 @ 11:19 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000838
Protocol Section: NCT00000838
Start Identification Module Data
Expand Identification Module Data
Brief Title: Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine Stavudine or Didanosine
Official Title: A Phase II Randomized Study of the Antiviral Activity and Resistance Interactions of Lamivudine 3TC in Combination With Zidovudine AZT Stavudine d4T or Didanosine ddI Versus Monotherapy With ddI or d4T in HIV-Infected Individuals With 200 - 600 CD4 Cellsmm3 and No Previous Nucleoside Experience
Acronym: None
Organization: National Institute of Allergy and Infectious Diseases NIAID
Organization Class: NIH
Organization Study ID: ACTG 306
Secondary IDs
Secondary ID Type Domain Link
11281 REGISTRY DAIDS ES Registry Number None
Start Status Module Data
Status Verified Date: 2021-10
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class: NIH
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload